EGFR-IN-129
EGFR-IN-129 (Compound 10b) is a potent and selective EGFR inhibitor, with an IC50 of 51.2 nM. EGFR-IN-129 exhibits broadest-spectrum antiproliferative activity against the NCI-tumor panel[1].
Product Specifications
UNSPSC
12352211
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-129.html
Smiles
COC1=CC(C2=NC(NC3=CC=C(S(=O)(N)=O)C=C3)=C(C=CC=C4)C4=N2)=CC=C1
Molecular Formula
C21H18N4O3S
Molecular Weight
406.46
References & Citations
[1]Eldehna WM, et al. Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors. Int J Biol Macromol. 2024 Nov;279 (Pt 2) :135010.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH033198-01 10 µg
Recombinant Human Uroplakin-2/UPK2 Protein (His Tag)
Sign In for Pricing
View Details PKSH033198-02 50 µg
Recombinant Human Uroplakin-2/UPK2 Protein (His Tag)
Sign In for Pricing
View Details 
TP303850L 1 mg
C9orf30 (MSANTD3) (NM_080655) Human Recombinant Protein
Sign In for Pricing
View Details ![PE/Cyanine5 Anti-Mouse CD24 Antibody[M1/69]](https://cdn.genprice.uk/products/763/68dd149e061270361e7d00d2/imageurl/e-ab-f1179ug.webp)
